Circio Holding ASA

OB:CRNA Stock Report

Market Cap: kr20.6m

Circio Holding Management

Management criteria checks 3/4

Circio Holding's CEO is Erik Wiklund, appointed in Oct 2021, has a tenure of 2.5 years. total yearly compensation is NOK3.79M, comprised of 67.3% salary and 32.7% bonuses, including company stock and options. directly owns 0.044% of the company’s shares, worth NOK9.00K. The average tenure of the management team and the board of directors is 2.5 years and 3.8 years respectively.

Key information

Erik Wiklund

Chief executive officer

kr3.8m

Total compensation

CEO salary percentage67.3%
CEO tenure2.5yrs
CEO ownership0.04%
Management average tenure2.5yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Targovax ASA's (OB:TRVX) Intrinsic Value Is Potentially 96% Above Its Share Price

Aug 24
Targovax ASA's (OB:TRVX) Intrinsic Value Is Potentially 96% Above Its Share Price

Health Check: How Prudently Does Targovax (OB:TRVX) Use Debt?

Jul 08
Health Check: How Prudently Does Targovax (OB:TRVX) Use Debt?

Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Oct 27
Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Is Targovax (OB:TRVX) A Risky Investment?

Jul 05
Is Targovax (OB:TRVX) A Risky Investment?

Shareholders May Be A Bit More Conservative With Targovax ASA's (OB:TRVX) CEO Compensation For Now

Mar 10
Shareholders May Be A Bit More Conservative With Targovax ASA's (OB:TRVX) CEO Compensation For Now

Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Feb 20
Is Targovax (OB:TRVX) Using Debt In A Risky Way?

The Chief Scientific Officer of Targovax ASA (OB:TRVX), Victor Levitsky, Just Bought A Few More Shares

Dec 05
The Chief Scientific Officer of Targovax ASA (OB:TRVX), Victor Levitsky, Just Bought A Few More Shares

CEO Compensation Analysis

How has Erik Wiklund's remuneration changed compared to Circio Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-kr111m

Sep 30 2023n/an/a

-kr446m

Jun 30 2023n/an/a

-kr449m

Mar 31 2023n/an/a

-kr440m

Dec 31 2022kr4mkr3m

-kr433m

Sep 30 2022n/an/a

-kr107m

Jun 30 2022n/an/a

-kr110m

Mar 31 2022n/an/a

-kr106m

Dec 31 2021kr3mkr2m

-kr98m

Sep 30 2021n/an/a

-kr98m

Jun 30 2021n/an/a

-kr97m

Mar 31 2021n/an/a

-kr105m

Dec 31 2020kr3mkr2m

-kr108m

Sep 30 2020n/an/a

-kr117m

Jun 30 2020n/an/a

-kr120m

Mar 31 2020n/an/a

-kr132m

Dec 31 2019kr2mkr2m

-kr148m

Sep 30 2019n/an/a

-kr153m

Jun 30 2019n/an/a

-kr162m

Mar 31 2019n/an/a

-kr153m

Dec 31 2018kr2mkr2m

-kr147m

Sep 30 2018n/an/a

-kr139m

Jun 30 2018n/an/a

-kr132m

Mar 31 2018n/an/a

-kr129m

Dec 31 2017kr942kkr883k

-kr122m

Compensation vs Market: Erik's total compensation ($USD343.87K) is about average for companies of similar size in the Norwegian market ($USD302.39K).

Compensation vs Earnings: Erik's compensation has increased whilst the company is unprofitable.

CEO

Erik Wiklund

2.5yrs

Tenure

kr3,791,000

Compensation

Dr. Erik Digman Wiklund serves as Chief Executive Officer of Circio Holding ASA (formerly known as Targovax ASA) since October 2021 and had been its Chief Business Officer since September 24, 2018 until Oc...

Leadership Team

NamePositionTenureCompensationOwnership
Erik Wiklund
Chief Executive Officer2.5yrskr3.79m0.044%
NOK 9.0k
Lubor Gaal
Chief Financial Officer2.1yrskr3.22mno data
Ola Melin
Chief Operating Officerless than a yearkr2.17m0.022%
NOK 4.5k
Victor Levitsky
Chief Scientific Officer3.9yrskr849.00k0.0044%
NOK 898.4
Thomas Hansen
Chief Technology Officerless than a yearno datano data
Jon Eriksen
Special Advisor6.3yrskr1.86mno data
Gustav Gaudernack
Chief Scientific Adviserno datano datano data
Peter Skorpil
Vice President of Business Development9yrskr1.07mno data

2.5yrs

Average Tenure

Experienced Management: CRNA's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Diane Mellett
Independent Non-Executive Director8.6yrskr355.00k0.054%
NOK 11.1k
Thomas Falck
Director2yrskr257.00kno data
Robert Burns
Independent Director8.8yrskr456.00k0.13%
NOK 26.9k
Damian Marron
Chairman of the Board4yrskr562.00kno data
Dmitriy Zamarin
Member of Medical Advisory Board3.5yrsno datano data
Dean Fennell
Member of Scientific Advisory Board3.5yrsno datano data

3.8yrs

Average Tenure

62yo

Average Age

Experienced Board: CRNA's board of directors are considered experienced (3.8 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.